2Gorter PM, Olijhoek JK, van der Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis, 2004,173:363-369.
3Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 2000,283:2404-2410.
4Nieto FJ, Iribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000,148:131-139.
5Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 2004,4:9.
6Costa A, Iguala I, Bedini J, et al. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism, 2002,51:372-375.
7Beard JT.Serum uric acid and coronary heart disease[J].Am Heart J,1983,106(2):397-400.
8Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographic proven coronary artery disease[J]. Am J Cardial,2002,89(1):12-17.
9Seinberg HO,Brecblel G,Jobonson A, et al.Insul-Inmediated sakeletal muscle vasolilatation is nitric oxide depedent[J].J Clin In Vest,1994,94(3):1172-1179.
10Becker BF.Towards the physiological function of uric acid[J].Free Radic Biol Med,1993,14(6):615-631.
